285 related articles for article (PubMed ID: 10823363)
21. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
22. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.
Schrader E
Int Clin Psychopharmacol; 2000 Mar; 15(2):61-8. PubMed ID: 10759336
[TBL] [Abstract][Full Text] [Related]
23. A hypericum extract in the treatment of depressive symptoms in outpatients: an open study.
Melzer J; Brignoli R; Keck ME; Saller R
Forsch Komplementmed; 2010 Mar; 17(1):7-14. PubMed ID: 20215757
[TBL] [Abstract][Full Text] [Related]
24. St. John's Wort extract: efficacy for menopausal symptoms of psychological origin.
Grube B; Walper A; Wheatley D
Adv Ther; 1999; 16(4):177-86. PubMed ID: 10623319
[TBL] [Abstract][Full Text] [Related]
25. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
[TBL] [Abstract][Full Text] [Related]
26. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
[TBL] [Abstract][Full Text] [Related]
28. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
Müller T; Mannel M; Murck H; Rahlfs VW
Psychosom Med; 2004; 66(4):538-47. PubMed ID: 15272100
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
Baca E; Garcia-Garcia M; Porras-Chavarino A
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
[TBL] [Abstract][Full Text] [Related]
30. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
Kasper S; Dienel A
Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
[TBL] [Abstract][Full Text] [Related]
31. [High dose St. John's wort extract as a phytogenic antidepressant].
Kasper S; Schulz V
Wien Med Wochenschr; 1999; 149(8-10):191-6. PubMed ID: 10483679
[TBL] [Abstract][Full Text] [Related]
32. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
33. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
34. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
Barnes J; Barber N; Wheatley D; Williamson EM
Planta Med; 2006 Mar; 72(4):378-82. PubMed ID: 16557483
[TBL] [Abstract][Full Text] [Related]
35. Black cohosh and St. John's wort for climacteric complaints: a randomized trial.
Uebelhack R; Blohmer JU; Graubaum HJ; Busch R; Gruenwald J; Wernecke KD
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):247-55. PubMed ID: 16449108
[TBL] [Abstract][Full Text] [Related]
36. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial.
van Die MD; Burger HG; Bone KM; Cohen MM; Teede HJ
Menopause; 2009; 16(1):156-63. PubMed ID: 18791483
[TBL] [Abstract][Full Text] [Related]
37. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
Kieser M; Szegedi A
Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
[TBL] [Abstract][Full Text] [Related]
38. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
Schulz V
Phytomedicine; 2002 Jul; 9(5):468-74. PubMed ID: 12222670
[TBL] [Abstract][Full Text] [Related]
39. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
Woelk H
BMJ; 2000 Sep; 321(7260):536-9. PubMed ID: 10968813
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
